Guanfacine
Based on 3 publication(s) in Google Scholar
Guanfacine is an orally active noradrenergic α2A agonist and has high selective for the α2A receptor subtype. Guanfacine has effects in producing hypotension and sedation. Guanfacine can be used for the research of a variety of prefrontal cortex (PFC) cognitive disorders, including tourette's syndrome and attention deficit hyperactivity disorder (ADHD).
For research use only. We do not sell to patients.
- Purity: 99.85%
- CAS No.: 29110-47-2
- Formula: C9H9Cl2N3O
- Molecular Weight:246.09
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Guanfacine
MoreAll Adrenergic Receptor Isoforms
More
Biological Activity
|
α adrenergic receptor |
Guanfacine increases the delay-related neuronal firing needed for working memory on dIPFC neurons at the cellular level[1][3].
Guanfacine improves PFC cognitive function by inhibiting the production of CAMP, closing HCN channels, and strengthening the PFC networks[1][3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Guanfacine improves cognitive performance when infused directly into the rat or monkey PFC[1][3].
Guanfacine blocks 2A receptors in the monkey dIPFC markedly impairs working memory, behavioral inhibition and greatly reduces persistent neuronal firing[1][3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 29110-47-2
-
Appearance Solid
-
Molecular Weight 246.09
-
Formula C9H9Cl2N3O
-
Color White to off-white
-
SMILES
O=C(NC(N)=N)CC1=C(Cl)C=CC=C1Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
A ventral pallidum-locus coeruleus-lateral hypothalamus pathway modulates brain arousal in freely behaving and isoflurane-anesthetized male mice. [Abstract]2025 May 16;16(1):4560. PMID: 40379709 -
Cell Rep Methods
RECOVER identifies synergistic drug combinations in vitro through sequential model optimization. [Abstract]2023 Oct 23;3(10):100599. PMID: 37797618 -
Solvent & Solubility
DMSO : 125 mg/mL (507.94 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (480 KB)
- English - EN (480 KB)
- Français - FR (480 KB)
- Deutsch - DE (480 KB)
- Norwegian - NO (480 KB)
- Español - ES (480 KB)
- Swedish - SV (480 KB)
- Italian - IT (480 KB)
- Korean - KR (480 KB)
- Portuguese - PT (480 KB)
-
Handling Instructions (2659 KB)
References
[1]. Amy F T Arnsten, et al. Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale. Yale J Biol Med. 2012 Mar;85(1):45-58. Epub 2012 Mar 29. [Content Brief]
[3]. Min Wang, et al. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell. 2007 Apr 20;129(2):397-410. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.0636 mL | 20.3178 mL | 40.6355 mL | 101.5889 mL |
| 5 mM | 0.8127 mL | 4.0636 mL | 8.1271 mL | 20.3178 mL | |
| 10 mM | 0.4064 mL | 2.0318 mL | 4.0636 mL | 10.1589 mL | |
| 15 mM | 0.2709 mL | 1.3545 mL | 2.7090 mL | 6.7726 mL | |
| 20 mM | 0.2032 mL | 1.0159 mL | 2.0318 mL | 5.0794 mL | |
| 25 mM | 0.1625 mL | 0.8127 mL | 1.6254 mL | 4.0636 mL | |
| 30 mM | 0.1355 mL | 0.6773 mL | 1.3545 mL | 3.3863 mL | |
| 40 mM | 0.1016 mL | 0.5079 mL | 1.0159 mL | 2.5397 mL | |
| 50 mM | 0.0813 mL | 0.4064 mL | 0.8127 mL | 2.0318 mL | |
| 60 mM | 0.0677 mL | 0.3386 mL | 0.6773 mL | 1.6931 mL | |
| 80 mM | 0.0508 mL | 0.2540 mL | 0.5079 mL | 1.2699 mL | |
| 100 mM | 0.0406 mL | 0.2032 mL | 0.4064 mL | 1.0159 mL |